Skip to content

Systematic review of the effects of GABA intake on elevated blood pressure

Systematic review of the effects of GABA intake on elevated blood pressure - SR of the effect of GABA intake on elevated blood pressure

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000056710
Enrollment
Unknown
Registered
2025-01-15
Start date
2025-01-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

None listed

Sponsors

Kyushu University
Lead Sponsor
Evaluation Center of Health and Nutrition Inc.
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: [Participants] Age: Adult (18 years old and over, no upper limit applies) Gender: Both men and women Health Condition: Healthy Include patients with normal hypertension and degree I hypertension with outpatient blood pressure BMI: Standard weight (18.5 to 25) and obesity 1 degree (25 to 30) [Intervention] Foods containing GABA (regardless of food form) should be taken orally. The duration of intake should not be less than 12 weeks. [Comparison] Intake of placebo without GABA [Outcomes] Evaluate whether there is a function of lowering blood pressure. [Research design] Conducting randomized controlled trials Studies that use foods that use multiple ingredients in addition to GABA as functional ingredients are not included Only peer-reviewed original papers are eligible.

Exclusion criteria

Exclusion criteria: Trials that include women who are pregnant or breastfeeding, women who are planning to become pregnant, or people who are being treated for hypertension. Studies with unknown GABA content. Papers citing the test results of the original paper, explanatory papers, abstracts of conference presentations, conference proceedings.

Design outcomes

Primary

MeasureTime frame
Blood pressure

Countries

Japan

Contacts

Public ContactSeiichi Hattori

Kurume Research Park Co., Ltd Bio Project Division

fbv@kurume-rp.co.jp0942-37-6124

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026